[HTML][HTML] The role of extracellular vesicles in acquisition of resistance to therapy in glioblastomas
Glioblastoma (GBM) is the most aggressive primary brain tumor with a median survival of 15
months despite standard care therapy consisting of maximal surgical debulking, followed by …
months despite standard care therapy consisting of maximal surgical debulking, followed by …
[HTML][HTML] Identification of new targets for glioblastoma therapy based on a DNA expression microarray
E Larriba, C de Juan Romero, A García-Martínez… - Computers in Biology …, 2024 - Elsevier
This study provides a comprehensive perspective on the deregulated pathways and
impaired biological functions prevalent in human glioblastoma (GBM). In order to …
impaired biological functions prevalent in human glioblastoma (GBM). In order to …
Multitarget Potential Drug Candidates for High-Grade Gliomas Identified by Multiple Reaction Monitoring Coupled with In Silico Drug Repurposing
A Verma, R Patel, A Mahale, RV Thorat… - OMICS: A Journal of …, 2024 - liebertpub.com
High-grade gliomas (HGGs) are extremely aggressive primary brain tumors with high
mortality rates. Despite notable progress achieved by clinical research and biomarkers …
mortality rates. Despite notable progress achieved by clinical research and biomarkers …
Identification of new targets for glioblastoma therapy based on a DNA expression microarray
E Larriba Tornel, C Juan Romero, A Garcia-Martinez… - 2024 - rua.ua.es
This study provides a comprehensive perspective on the deregulated pathways and
impaired biological functions prevalent in human glioblastoma (GBM). In order to …
impaired biological functions prevalent in human glioblastoma (GBM). In order to …
Preclinical interrogation of novel Immunotherapy treatment strategies in Glioblastoma (GBM) using a novel clinically relevant disease model
J Clerkin - 2023 - repository.rcsi.com
Reliable and clinically faithful pre-clinical glioblastoma (GBM) models are essential for the
screening of new therapies and to understand treatment resistance mechanisms. Historically …
screening of new therapies and to understand treatment resistance mechanisms. Historically …